Virtonomy Receives Investment from Accenture Ventures
Summary
Virtonomy, a Munich, Germany-based provider of data-driven Med Tech simulations, received an investment from Accenture Ventures. The company intends to use the funds to further extend its capabilities to medical technology (MedTech) companies. Founded in late 2019 by Dr. Simon Sonntag (CEO) and Wen-Yang Chu (CTO), Virtonomy develops a cloud-based solution, enabling the continued digitalization of the design and execution phases of clinical studies for medical devices using digital patient twins based on a large amount of imaging, physiological and pathological data. Its digital twin simulation solution enables medical device manufacturers to build virtual environments for device testing at a reduced cost and with a lesser degree of regulatory complexity. The solution is based on a database of real clinical data that reflects factors such as anatomical variability, demographic diversity, and pathological conditions.
Funding
Review available funding amount, funding date, investors, and linked company information related to Virtonomy Receives Investment from Accenture Ventures in the interactive ISVWorld profile.